Bioresponsive Hyaluronic Acid‐Based Hydrogel Inhibits Matrix Metalloproteinase‐2 in Glioblastoma Microenvironment

Glioblastoma multiforme (GBM) is an extremely malignant cancer, resistant to standard therapies. Tumor resection is associated with better outcomes but a complete resection of GBMs is challenging for anatomical limitation and for the high degree of invasiveness. A bioresponsive hydrogel based on hyaluronic acid (HA) cross-linked with a branched metalloproteinase (MMP) inhibitor (MMPI) is proposed. The fully characterized hydrogel, HA-MMPI, presents physical properties suitable for filling the surgical resection cavity and for in situ delivery of the inhibitor. The bioresponsive material selectively inhibits MMP-2 versus MMP-9 in glioblastoma microenvironment.

Authors

Institutions

Publication Details

Journal
ChemMedChem
Published
2025-06-24
DOI
https://doi.org/10.1002/cmdc.202401040
Citations
4
Primary Topic
Proteoglycans and glycosaminoglycans research
Type
article
Field-Weighted Citation Impact
4.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bioresponsive Hyaluronic Acid‐Based Hydrogel Inhibits Matrix Metalloproteinase‐2 in Glioblastoma Microenvironment

Domenico Salerno, Laura Russo, Gemma Leone, Francesco Mantegazza et al.
4 citations
ChemMedChem
Proteoglycans and glycosaminoglycans research
4.61
article

Bioresponsive Hyaluronic Acid‐Based Hydrogel Inhibits Matrix Metalloproteinase‐2 in Glioblastoma Microenvironment

Domenico Salerno, Laura Russo, Gemma Leone, Francesco Mantegazza, Luca Crippa, Federica Barbugian, Luigi Talarico, E Ballarini, Stefano Roelens, Cristina Nativi, Agnese Magnani, Simone Pepi, Oscar Francesconi, Guido Cavaletti
article en
4 citations

Abstract

Glioblastoma multiforme (GBM) is an extremely malignant cancer, resistant to standard therapies. Tumor resection is associated with better outcomes but a complete resection of GBMs is challenging for anatomical limitation and for the high degree of invasiveness. A bioresponsive hydrogel based on hyaluronic acid (HA) cross-linked with a branched metalloproteinase (MMP) inhibitor (MMPI) is proposed. The fully characterized hydrogel, HA-MMPI, presents physical properties suitable for filling the surgical resection cavity and for in situ delivery of the inhibitor. The bioresponsive material selectively inhibits MMP-2 versus MMP-9 in glioblastoma microenvironment.

ChemMedChemVol. 20(15)
University of Siena (IT), National Interuniversity Consortium of Materials Science and Technology (IT), University of Florence (IT), University of Milano-Bicocca (IT)
Dipartimenti di Eccellenza, Università degli Studi di Firenze
Good health and well-being
Openalex Percentile: Top 5%
Proteoglycans and glycosaminoglycans research
4.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.